Riccardo Canevari

Company: RadioPharm Theranostics

Job title: CEO

Seminars:

Bringing Novel Targets to the Clinic 1:30 pm

Novel target selection to expand use in different solid tumors Vector selection: Small molecules or mAb or both? Sharing topline clinical imaging dataRead more

day: Day 2 - P&T Track PM

Panel Discussion: Phase 0 for Radiopharmaceuticals: Benefits & Risks 12:00 pm

Uncovering the rationale behind conducting these preliminary studies Exploring the pharmacokinetic and pharmacodynamic data it can provide Considerations for initiating a phase 0 trialRead more

day: P&T Track AM